Skip to content

RapidCross™ A14BX020060170Recalls & reported problems

Covidien LP · PTA A14BX020060170 RAPIDCROSS V04 · Class 2

All models of RapidCross (26)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00763000110611), received between Feb 3, 2022 and Feb 3, 2022 — classified as 1 malfunction.

The most frequently reported specific device problem is “Detachment of Device or Device Component” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Most reported problems

Device problems

  • Detachment of Device or Device Component1

Patient problems

  • Device Embedded In Tissue or Plaque1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • MalfunctionFeb 3, 2022Detachment of Device or Device Component; Detachment of Device or Device Component

    PHYSICIAN WAS ATTEMPTING TO USE THE RAPIDCROSS PTA BALLOON DURING PROCEDURE. IT WAS REPORTED THAT WHILE PERFORMING AN INTERVENTION ON AN ARTERIAL LOWER EXTREMITY CHRONIC TOTAL OCCLUSION,AN ANGIOPLASTY BALLOON WAS INFLATED WITHIN THE LESION. AT SOME POINT THEREAFTER THE PHYSICIAN WAS ATTEMPTING TO REMOVE THE BALLOON AND IT BECAME DETACHED FROM THE SHAFT (CATHETER) WITHIN THE ARTERY. DEVICE REMAINS IN PATIENT.

    Patient problems: Device Embedded In Tissue or Plaque

    MAUDE report 13440618 ↗

Other Catheter, angioplasty, peripheral, transluminal devices

All Catheter, angioplasty, peripheral, transluminal devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page